\-\ Texto\\:\\ \ \(0\)\
\-\ bp\\ 99\\/60\\,\\ t\\ \\=\\ 101\\,\\ hr\\ 120\ \(0\)\
\-\ ua\\ \\+\\ leuk\\ est\\,\\ many\\ wbc\\,\\ many\\ bacteria\ \(0\)\
\-\ vauge\\ abd\\ and\\ flank\\ pain\\.\ \(1\)\
\-\ the\\ patient\\ received\\ antibiotics\\ and\\ recovered\\ well\\.\ \(0\)\
\-\ bilateral\\ striated\\ nephrograms\\,\\ l\\>r\\:\ \(0\)\
\-\ wedge\\ shaped\\ areas\\ of\\ decreased\\ enhancement\\ compared\\ to\\ normal\\ renal\\ parenchyma\\ with\\ associated\\ perinephric\\ fat\\ stranding\\ indicating\\ areas\\ of\\ edema\\ and\\ inflammation\\ in\\ the\\ kidneys\\.\ \(1\)\
\-\ pyelonephritis\ \(60\)\
\-\ \\â\\€\\¢\\ acute\\ pyelonephritis\ \(0\)\
\-\ \\â\\€\\¢\\ lobar\\ nephronia\ \(0\)\
\-\ \\â\\€\\¢\\ distal\\ obstruction\ \(0\)\
\-\ \\â\\€\\¢\\ tubular\\ obstruction\ \(0\)\
\-\ \\â\\€\\¢\\ trauma\\/contusion\ \(0\)\
\-\ \\â\\€\\¢\\ renal\\ vein\\ thrombosis\ \(0\)\
\-\ 21\\ yo\\ female\\ with\\ fever\\,\\ hypotension\\ and\\ flank\\ pain\\.\ \(0\)\
\-\ acute\\ pyelonephritis\\ is\\ caused\\ by\\ bacterial\\ infection\\ that\\ has\\ ascended\\ from\\ the\\ lower\\ urinary\\ tract\\ or\\,\\ \\ by\\ hematogenous\\ spread\\.\\ \\ antibiotics\\ typically\\ make\\ this\\ disease\\ easily\\ managed\\;\\ however\\,\\ complications\\ may\\ occur\\.\ \(0\)\
\-\ pyelonephritis\\ becomes\\ a\\ potentially\\ fatal\\ disease\\ when\\ secondary\\ conditions\\ develop\\,\\ such\\ as\\ emphysematous\\ pyelonephritis\\ \\(20\\-80\\%\\ mortality\\ rate\\)\\,\\ perinephric\\ abscess\\ \\(20\\-50\\%\\ mortality\\ rate\\)\\,\\ or\\ one\\ of\\ the\\ sepsis\\ syndromes\\ \\(\\>25\\%\\ overall\\ mortality\\ rate\\)\\.\\ \ \(0\)\
\-\ ct\\ is\\ generally\\ used\\ in\\ the\\ evaluation\\ of\\ pyelonephritis\\ to\\ asses\\ for\\ complications\\.\\ \\ long\\ term\\ complications\\ include\\ renal\\ scarring\\ and\\ potentially\\ decreased\\ renal\\ function\\ if\\ repetitive\\ infections\\ occur\\.\\ \\ the\\ most\\ common\\ pathogen\\ is\\ e\\.\\ coli\\ \\(70\\-80\\%\\)\\.\\ \\ others\\ include\\ enterococcus\\ faecalis\\,\\ klebsiella\\,\\ and\\ pseudomonas\\ aeruginosa\\.\\ \ \(0\)\
\-\ another\\ good\\ referrence\\ is\\:\ \(0\)\
\-\ \\"the\\ ct\\ nephrogram\\:\\ implications\\ for\\ evaluation\\ of\\ urinary\\ tract\\ disease\\"\\ \\ radiographics\\.\\ \\ 1995\\;\\ 15\\:1069\\-1085\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.42566033780482565\ \(0\)\
\-\ mortality\\:\\ 0\\.20158938663681364\ \(0\)\
\-\ renal\\:\\ 0\\.17016644274127662\ \(0\)\
\-\ complications\\:\\ 0\\.15696557789808105\ \(0\)\
\-\ rate\\:\\ 0\\.15530126064171515\ \(0\)\
\-\ perinephric\\:\\ 0\\.15285270534395476\ \(0\)\
\-\ potentially\\:\\ 0\\.14340002759909834\ \(0\)\
\-\ flank\\:\\ 0\\.11984240468031379\ \(0\)\
\-\ urinary\\:\\ 0\\.11815098692896615\ \(0\)\
\-\ tract\\:\\ 0\\.11445880088335833\ \(0\)\
\-\ nephronia\\:\\ 0\\.10925037686999\ \(0\)\
\-\ referrence\\:\\ 0\\.10925037686999\ \(0\)\
\-\ many\\:\\ 0\\.1077243361357277\ \(0\)\
\-\ nephrograms\\:\\ 0\\.1043945675546648\ \(0\)\
\-\ faecalis\\:\\ 0\\.1043945675546648\ \(0\)\
\-\ leuk\\:\\ 0\\.10094931601679197\ \(0\)\
\-\ vauge\\:\\ 0\\.10094931601679197\ \(0\)\
\-\ aeruginosa\\:\\ 0\\.10094931601679197\ \(0\)\
\-\ antibiotics\\:\\ 0\\.10065836122276521\ \(0\)\
\-\ occur\\:\\ 0\\.1004841655556557\ \(0\)\
\-\ ascended\\:\\ 0\\.09827697131077787\ \(0\)\
\-\ enterococcus\\:\\ 0\\.09827697131077787\ \(0\)\
\-\ asses\\:\\ 0\\.09609350670146674\ \(0\)\
\-\ pathogen\\:\\ 0\\.09609350670146674\ \(0\)\
\-\ klebsiella\\:\\ 0\\.09609350670146674\ \(0\)\
\-\ pseudomonas\\:\\ 0\\.09609350670146674\ \(0\)\
\-\ obstruction\\:\\ 0\\.09570142094868758\ \(0\)\
\-\ the\\:\\ 0\\.09541906758372695\ \(0\)\
\-\ areas\\:\\ 0\\.09276214137191144\ \(0\)\
\-\ implications\\:\\ 0\\.09264825516359393\ \(0\)\
\-\ est\\:\\ 0\\.08997591045757981\ \(0\)\
\-\ disease\\:\\ 0\\.08602848825821871\ \(0\)\
\-\ striated\\:\\ 0\\.08594635282546478\ \(0\)\
\-\ nephrogram\\:\\ 0\\.08512010114225459\ \(0\)\
\-\ and\\:\\ 0\\.08469861041598818\ \(0\)\
\-\ decreased\\:\\ 0\\.0846312872336726\ \(0\)\
\-\ evaluation\\:\\ 0\\.08332450142813655\ \(0\)\
\-\ include\\:\\ 0\\.08129347185549339\ \(0\)\
\-\ coli\\:\\ 0\\.08109054351013956\ \(0\)\
\-\ fatal\\:\\ 0\\.08000107465274722\ \(0\)\
\-\ repetitive\\:\\ 0\\.07808082721761826\ \(0\)\
\-\ hematogenous\\:\\ 0\\.07764529197226674\ \(0\)\
\-\ emphysematous\\:\\ 0\\.07681904028905655\ \(0\)\
\-\ bacteria\\:\\ 0\\.07567761517087918\ \(0\)\
\-\ 101\\:\\ 0\\.07497294726625263\ \(0\)\
\-\ recovered\\:\\ 0\\.07497294726625263\ \(0\)\
\-\ is\\:\\ 0\\.07483398399560191\ \(0\)\
\-\ 120\\:\\ 0\\.07463557567974544\ \(0\)\
\-\ sepsis\\:\\ 0\\.07463557567974544\ \(0\)\
\-\ hypotension\\:\\ 0\\.07398807208092055\ \(0\)\
\-\ acute\\:\\ 0\\.07391148433281512\ \(0\)\
\-\ 1995\\:\\ 0\\.07367699227078456\ \(0\)\
\-\ others\\:\\ 0\\.07196323097373132\ \(0\)\
\-\ wedge\\:\\ 0\\.07144245765091653\ \(0\)\
\-\ lobar\\:\\ 0\\.07046428977425993\ \(0\)\
\-\ scarring\\:\\ 0\\.07046428977425993\ \(0\)\
\-\ syndromes\\:\\ 0\\.07023174073291173\ \(0\)\
\-\ radiographics\\:\\ 0\\.06892398100575643\ \(0\)\
\-\ easily\\:\\ 0\\.06832002617974478\ \(0\)\
\-\ of\\:\\ 0\\.06684460527106795\ \(0\)\
\-\ managed\\:\\ 0\\.06684420448422394\ \(0\)\
\-\ make\\:\\ 0\\.06633451482654738\ \(0\)\
\-\ becomes\\:\\ 0\\.06537593141758652\ \(0\)\
\-\ ua\\:\\ 0\\.06522337012735163\ \(0\)\
\-\ indicating\\:\\ 0\\.06463184746204018\ \(0\)\
\-\ bacterial\\:\\ 0\\.0639313027798083\ \(0\)\
\-\ abd\\:\\ 0\\.0635298383947826\ \(0\)\
\-\ develop\\:\\ 0\\.06288926328867457\ \(0\)\
\-\ overall\\:\\ 0\\.06276515959438944\ \(0\)\
\-\ conditions\\:\\ 0\\.06240038319197157\ \(0\)\
\-\ spread\\:\\ 0\\.06136832777755367\ \(0\)\
\-\ stranding\\:\\ 0\\.06115057815468151\ \(0\)\
\-\ infections\\:\\ 0\\.06031713589825798\ \(0\)\
\-\ received\\:\\ 0\\.059444011750801745\ \(0\)\
\-\ tubular\\:\\ 0\\.05935081362031892\ \(0\)\
\-\ kidneys\\:\\ 0\\.058806360805208055\ \(0\)\
\-\ hr\\:\\ 0\\.05871797738318907\ \(0\)\
\-\ by\\:\\ 0\\.058020926404154446\ \(0\)\
\-\ generally\\:\\ 0\\.05786826653610724\ \(0\)\
\-\ shaped\\:\\ 0\\.05707487056438847\ \(0\)\
\-\ another\\:\\ 0\\.055905562082446084\ \(0\)\
\-\ thrombosis\\:\\ 0\\.05569848085384243\ \(0\)\
\-\ good\\:\\ 0\\.055562389624269626\ \(0\)\
\-\ parenchyma\\:\\ 0\\.05549491959044897\ \(0\)\
\-\ bp\\:\\ 0\\.05542782754199383\ \(0\)\
\-\ function\\:\\ 0\\.055294760624903294\ \(0\)\
\-\ compared\\:\\ 0\\.05522877754158455\ \(0\)\
\-\ inflammation\\:\\ 0\\.05490420755899759\ \(0\)\
\-\ caused\\:\\ 0\\.054776803173093025\ \(0\)\
\-\ 21\\:\\ 0\\.05458820243547651\ \(0\)\
\-\ term\\:\\ 0\\.05357218055033297\ \(0\)\
\-\ ct\\:\\ 0\\.05201623792462761\ \(0\)\
\-\ used\\:\\ 0\\.0511429508976037\ \(0\)\
\-\ vein\\:\\ 0\\.0489672856368763\ \(0\)\
\-\ pain\\:\\ 0\\.04889116145468256\ \(0\)\
\-\ 25\\:\\ 0\\.04839598975502394\ \(0\)\
\-\ wbc\\:\\ 0\\.048284929614487423\ \(0\)\
\-\ typically\\:\\ 0\\.04795779821614328\ \(0\)\
\-\ or\\:\\ 0\\.04753106565062706\ \(0\)\
\-\ fever\\:\\ 0\\.04631836949913051\ \(0\)\
\-\ long\\:\\ 0\\.045299804499655975\ \(0\)\
\-\ such\\:\\ 0\\.04394361730258888\ \(0\)\
\-\ abscess\\:\\ 0\\.04386693038530829\ \(0\)\
\-\ yo\\:\\ 0\\.042679266216148405\ \(0\)\
\-\ fat\\:\\ 0\\.04249607489157252\ \(0\)\
\-\ for\\:\\ 0\\.04141143604713754\ \(0\)\
\-\ infection\\:\\ 0\\.04126614482971115\ \(0\)\
\-\ when\\:\\ 0\\.04126614482971115\ \(0\)\
\-\ edema\\:\\ 0\\.040744498914136534\ \(0\)\
\-\ secondary\\:\\ 0\\.040491956399121794\ \(0\)\
\-\ however\\:\\ 0\\.040434425947443654\ \(0\)\
\-\ distal\\:\\ 0\\.039692647132960196\ \(0\)\
\-\ if\\:\\ 0\\.039692647132960196\ \(0\)\
\-\ enhancement\\:\\ 0\\.03932085986905142\ \(0\)\
\-\ one\\:\\ 0\\.03911347980701268\ \(0\)\
\-\ common\\:\\ 0\\.03874236590757412\ \(0\)\
\-\ bilateral\\:\\ 0\\.036714941282021504\ \(0\)\
\-\ associated\\:\\ 0\\.036007068480252126\ \(0\)\
\-\ most\\:\\ 0\\.03555313598563997\ \(0\)\
\-\ lower\\:\\ 0\\.03490898200765953\ \(0\)\
\-\ may\\:\\ 0\\.03437820536295036\ \(0\)\
\-\ to\\:\\ 0\\.034157175231472645\ \(0\)\
\-\ in\\:\\ 0\\.03398905368572527\ \(0\)\
\-\ well\\:\\ 0\\.033078405159766795\ \(0\)\
\-\ female\\:\\ 0\\.032965083976513106\ \(0\)\
\-\ has\\:\\ 0\\.031204249956371277\ \(0\)\
\-\ that\\:\\ 0\\.02964609914183037\ \(0\)\
\-\ normal\\:\\ 0\\.027892510384648926\ \(0\)\
\-\ as\\:\\ 0\\.02744451472028935\ \(0\)\
\-\ from\\:\\ 0\\.02713177695612318\ \(0\)\
\-\ with\\:\\ 0\\.02675381796271569\ \(0\)\
\-\ this\\:\\ 0\\.023474225501512614\ \(0\)\
\-\ patient\\:\\ 0\\.022219403329952685\ \(0\)\
